IQVIA Holdings Inc
IQV220.880USD
+2.350+1.08%
Close 11/12, 16:00（ET）Quotes delayed by 15 min
37.62BMarket Cap
29.32P/E TTM
More Details of IQVIA Holdings Inc Company
IQVIA Holdings Inc. is a provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. Its segments include Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. Technology & Analytics Solutions segment offers mission-critical information, technology solutions and real-world insights and services to its life science clients. Research & Development Solutions segment serves biopharmaceutical customers and provides outsourced clinical research and clinical trial related services. Contract Sales & Medical Solutions segment offers health care providers (including contract sales) and patient engagement services to both biopharmaceutical clients and the broader healthcare market. Its Connected Intelligence delivers insights and solutions enabling customers to accelerate the clinical development and commercialization of medical treatments that improve healthcare outcomes for patients.
IQVIA Holdings Inc Info
Ticker SymbolIQV
Company nameIQVIA Holdings Inc
IPO dateMay 09, 2013
CEOMr. Ari Bousbib
Number of employees88000
Security typeOrdinary Share
Fiscal year-endMay 09
Address2400 Ellis Road
CityDURHAM
Stock exchangeNYSE Consolidated
CountryUnited States of America
Postal code27703
Phone19199982000
Websitehttps://ir.iqvia.com/
Ticker SymbolIQV
IPO dateMay 09, 2013
CEOMr. Ari Bousbib
Company Executives of IQVIA Holdings Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Ari Bousbib
Mr. Ari Bousbib
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.35M
--
Mr. Ronald E. (Ron) Bruehlman
Mr. Ronald E. (Ron) Bruehlman
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
46.46K
-1.91%
Mr. John G. Danhakl
Mr. John G. Danhakl
Independent Director
Independent Director
30.85K
-79.16%
Mr. Eric M. Sherbet
Mr. Eric M. Sherbet
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
21.11K
--
Ms. Colleen A. Goggins
Ms. Colleen A. Goggins
Independent Director
Independent Director
16.83K
+10.45%
Dr. John M. Leonard, M.D.
Dr. John M. Leonard, M.D.
Lead Independent Director
Lead Independent Director
15.38K
+11.55%
Ms. Carol J. Burt
Ms. Carol J. Burt
Independent Director
Independent Director
7.01K
+17.56%
Mr. James A. Fasano
Mr. James A. Fasano
Independent Director
Independent Director
2.74K
+157.67%
Mr. John P. Connaughton
Mr. John P. Connaughton
Independent Director
Independent Director
1.05K
--
Mr. Bhavik Patel
Mr. Bhavik Patel
President, Commercial Solutions
President, Commercial Solutions
863.00
-8.87%
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Ari Bousbib
Mr. Ari Bousbib
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.35M
--
Mr. Ronald E. (Ron) Bruehlman
Mr. Ronald E. (Ron) Bruehlman
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
46.46K
-1.91%
Mr. John G. Danhakl
Mr. John G. Danhakl
Independent Director
Independent Director
30.85K
-79.16%
Mr. Eric M. Sherbet
Mr. Eric M. Sherbet
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
21.11K
--
Ms. Colleen A. Goggins
Ms. Colleen A. Goggins
Independent Director
Independent Director
16.83K
+10.45%
Dr. John M. Leonard, M.D.
Dr. John M. Leonard, M.D.
Lead Independent Director
Lead Independent Director
15.38K
+11.55%
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
No Data
By RegionUSD
Name
Revenue
Proportion
Americas
1.94B
48.17%
Europe & Africa Region
1.24B
30.89%
Asia Pacific Region
841.00M
20.94%
By Business
By Region
No Data
Shareholding Stats
Updated: Fri, Oct 31
Updated: Fri, Oct 31
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
11.40%
Harris Associates L.P.
6.90%
BlackRock Institutional Trust Company, N.A.
5.50%
State Street Investment Management (US)
4.48%
GIC Private Limited
3.84%
Other
67.88%
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
11.40%
Harris Associates L.P.
6.90%
BlackRock Institutional Trust Company, N.A.
5.50%
State Street Investment Management (US)
4.48%
GIC Private Limited
3.84%
Other
67.88%
Shareholder Types
Shareholders
Proportion
Investment Advisor
48.20%
Investment Advisor/Hedge Fund
34.87%
Hedge Fund
7.16%
Sovereign Wealth Fund
4.96%
Pension Fund
4.16%
Research Firm
2.49%
Bank and Trust
2.06%
Individual Investor
0.91%
Family Office
0.13%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
2061
175.98M
103.33%
-829.63K
2025Q2
2053
166.70M
98.05%
-9.45M
2025Q1
2083
168.53M
97.38%
-9.36M
2024Q4
2059
171.87M
97.45%
+3.00M
2024Q3
2008
173.01M
95.44%
+863.78K
2024Q2
1977
164.85M
90.43%
-7.68M
2024Q1
1950
165.50M
90.84%
-10.38M
2023Q4
1948
168.90M
93.03%
-6.38M
2023Q3
1925
170.01M
92.82%
-4.41M
2023Q2
1898
167.84M
91.62%
-8.26M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
The Vanguard Group, Inc.
19.60M
11.53%
-162.29K
-0.82%
Jun 30, 2025
Harris Associates L.P.
11.75M
6.91%
+583.80K
+5.23%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
9.37M
5.51%
-507.18K
-5.13%
Jun 30, 2025
State Street Investment Management (US)
7.62M
4.49%
-98.36K
-1.27%
Jun 30, 2025
GIC Private Limited
6.54M
3.85%
-2.59M
-28.36%
Mar 31, 2025
Geode Capital Management, L.L.C.
4.22M
2.48%
-16.90K
-0.40%
Jun 30, 2025
CPP Investments
4.17M
2.45%
-426.35K
-9.28%
Jun 30, 2025
Farallon Capital Management, L.L.C.
3.85M
2.27%
+439.50K
+12.88%
Jun 30, 2025
AllianceBernstein L.P.
3.56M
2.09%
+19.57K
+0.55%
Jun 30, 2025
Artisan Partners Limited Partnership
3.27M
1.93%
+3.27M
--
Jun 30, 2025
View more
Related ETFs
Updated: Thu, Nov 6
Updated: Thu, Nov 6
Name
Proportion
First Trust Nasdaq Lux Digi Health Solutions ETF
7.97%
Global X HealthTech ETF
5.5%
VanEck Biotech ETF
4.63%
Langar Global HealthTech ETF
4.46%
Adaptive Core ETF
3.04%
iShares Biotechnology ETF
3.03%
iShares ESG Aware MSCI USA Value ETF
2.37%
Invesco Bloomberg Pricing Power ETF
1.96%
American Century Focused Large Cap Value ETF
1.93%
Running Oak Efficient Growth ETF
1.87%
View more
First Trust Nasdaq Lux Digi Health Solutions ETF
Proportion7.97%
Global X HealthTech ETF
Proportion5.5%
VanEck Biotech ETF
Proportion4.63%
Langar Global HealthTech ETF
Proportion4.46%
Adaptive Core ETF
Proportion3.04%
iShares Biotechnology ETF
Proportion3.03%
iShares ESG Aware MSCI USA Value ETF
Proportion2.37%
Invesco Bloomberg Pricing Power ETF
Proportion1.96%
American Century Focused Large Cap Value ETF
Proportion1.93%
Running Oak Efficient Growth ETF
Proportion1.87%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
